The vacancy against the covid-19 developed by Oxford / AstraZeneca has an efficiency of 76% over the first injection, while this figure rises to 82% over a second inoculated dose over an interval of “12 weeks”, según revela hoy un studio published by The Lancet.
On the other hand, the preliminary results of a study conducted by the University of Oxford between 17,178 subjects indicate that the efficacy of this antigen preparation is 55% when the interval quoted is six weeks.
“It is suggested that the interval between doses can be extended with security to three months, given the protection that a single dose is given“which allows the vacancies to have a proportionate mayor of population more rapidly”, the authors explain in a statement.
This work also includes updated estimates regarding the general efficacy of the vaccine against covid in asymptomatic patients, and concludes that it is effective through the administration of the dose.
Oxford’s evacuation team chief investigator Andrew Pollard recorded that the evacuation summit manager “will be safe, limited”, but at the “short spot”, the authorities will decide which calendar will be safe to log the maximum benefit of public health “.
“When it comes to nurses, the decision to vaccinate first with a single dose can only be offered immediately to the protection of the population, while evacuating the person at the dose dose”, said Pollard.
On a large scale, aggregate, the second dose should be guaranteed a “lasting dose” and, by this, he animated all the ones he received the first dose for “being assured of receiving both doses”.
The study shows that other vaccines are being developed to combat Ebola, malaria or influenza, for example, also offer more protection and reduce immunological responses when existing “long intervals” occur between doses.